I NVITED PRESENTATIONS JULY 1, 20 10 – JUNE 30, 20 1 1
Michelle Alfa
“Flexible Endoscopes: The “A,B,C’s” of Monitoring Manual Cleaning Efficacy!”. Presented at The Food and Drug Administration Reprocessing of Reusable Medical Devices Workshop. Silver Spring, Maryland. June 8-9, 2011.
“How Clean is “Clean Enough” when Reprocessing Surgical Instruments?” Presented at The Food and Drug Administration Reprocessing of Reusable Medical Devices Workshop. Silver Spring, Maryland. June 8-9, 2011.
“Medical Device Reprocessing: 911 call” Presented at the Johnson & Johnson Reprocessing – from the Basement to the Boardroom symposium. Toronto, ON. June 4, 2011.
“Optimisation of follow-up samples for patients with pulmonary tuberculosis” Presented at 21st European Congress of Clinical Microbiology and Infectious Disease and the 27th International Congress of Chemotherapy. Milan, Italy. May 7-10, 2011.
“Cleaning and Disinfection Practices” Presented at the Provincial Infection Control Network of British Columbia conference. Richmond, BC. April 7-8, 2011.
“TB Diagnostics and Follow-up” Presented at the WRHA Regional Tuberculosis Workshop. Winnipeg, Manitoba. March 24, 2011.
“Clostridium difficile: The Sinister Spore Saga” Webber Teleconference, December 16, 2010.
“Clostridium difficile: What to do to contain the Poo!” Clostridium difficile Symposium, Winnipeg, MB, December 7, 2010.
“Advancements in Endoscope Reprocessing: Lowering Risk of Infection Transmission”. Johnson and Johnson Webinar, November 15, 2010.
“Reprocessing of Implants: What are the Issues?” Presented at the 11th World Sterilization Congress & 7th Int’l Symposium of Sterilization & Hospital Infection Control. Sau Paulo, Brazil. July 30 – August 1, 2010.
“Monitoring Flexible Endoscope Channels to Assure Cleaning” Presented at the 11th World Sterilization Congress & 7th Int’l Symposium of Sterilization & Hospital Infection Control. Sau Paulo, Brazil. July 30 – August 1, 2010.
“Enzymatic Detergent: role in cleaning of Medical Instruments” Presented at the 11th World Sterilization Congress & 7th Int’l Symposium of Sterilization & Hospital Infection Control. Sau Paulo, Brazil. July 30 – August 1, 2010.
Fred Aoki
Antiviral Drugs for the Prevention & Treatment of Illness due to Seasonal and Pandemic Influenza Viruses. Toronto Invasive Bacterial Diseases Network Education Day. Toronto, Ontario.
Harvey Artsob
Studying zoonotic diseases: past and present approaches. Keynote banquet speaker. International Conference on Diseases in Nature Communicable to Man. August 8-10, Fairbanks, Alaska, 2010.
Arboviruses relevant to the northern ecology. Zoonotic and Parasitic Infections in Alaska (Z-PAK): Climate change and the potential impact on disease distribution and prevalence. August 11-12, Fairbanks, Alaska, 2010.
Factors influencing disease emergence. Annual International Symposium Biosecurity and Biosafety: Future trends and solutions. October 13-15, Milan, Italy, 2010.
Addressing emerging diseases of animal origin. D.L.T. Smith Lecture. Western College of Veterinary Medicine. February 8, Saskatoon, Saskatchewan, 2011.
Addressing emerging disease issues: experiences of a zoonotic diseases scientist. Keynote speaker for 50th Gala celebration of the School of Occupational & Public Health. Reyerson University. March 26, Toronto, Ontario. 2011.
Blake Ball
Comparative proteomic analysis of mucosal samples from the female genital tract Invited Talk: HIV Mucosal Immunology Group Meeting, Apr 12, 2011, Seattle Washington.
Recent activities of the National Laboratory for HIV Immunology Invited Talk: International HIV Prevention Exchange Symposium Saturday, January 29, 2011, Winnipeg, Manitoba.
Correlates of protection against HIV infection: Studies of HIV Exposed, Seronegative subjects (HESN) Invited Talk
University of Nairobi Annual Review meeting 2011, Jan 17-21, 2011, Nairobi, Kenya.
QASI: An International External Quality Assessment (EQA) Program Invited Talk: University of Nairobi Annual Review meeting 2011, Jan 17-21, 2011, Nairobi, Kenya.
Proteomic analysis of different “compartments” in the female genital tract Invited Talk: HIV Mucosal Immunology Group meeting June 25, 2010 Los Angeles California.
Coordinating Medical Research and Education in Times of Crisis Invited Talk: East-West Alliance 2010 Conference, Winnipeg, Manitoba, June 3, 2010.
Kathryn Bernard
Updated look at Corynebacterium species and other medically-relevant, fastidious or good-growing Gram positive Rods, an all day workshop for the South Western Association of Clinical Microbiology (‘SWACM’) held May 21, 2010 in Arlington TX. Part One: Overview and Corynebacterium species; Part Two: Coryneforms and other Gram Positive Rods.
16S rRNA gene Sequencing. The Good, the Bad and the Ugly. A presentation to the National Molecular Group (NMG) October 19 2010, St, Joseph’s Hospital, Hamilton On.
An overview of the Canadian National Microbiology Laboratory and Special Bacteriology Section. October 27, 2010 at the State Research Institute, Obolensk, Russia.
A Review of Medically Relevant Corynebacterium species and other ‘Coryneforms’. November 16, 2010 for the Teleconference Network of Texas, San Antonio TX.
A Review of Medically Relevant Corynebacterium species and other ‘Coryneforms’. January 31, 2011, Health Protection Agency, Colindale UK.
A Review of Genera Leptotrichia and Sneathia: Evidence of Additional Heterogenity. Delivered as part of the ICSP –Gram Negative Anaerobes subcommittee meeting, Feb 2, 2011 at the Health Protection Agency, Colindale UK.
James Blanchard
September, 2010: “Programs and Science: Seeking the Academic Mission in Global Health”. Consortium of Universities for Global Health Annual Meeting. University of Washington, Seattle, USA.
Timothy Booth
On-camera interview and appearance for the show Finding Stuff Out, a science-based kids TV show being produced for TVO, Monday, June 13th, 2011.
On-camera appearance for the Discovery Channel Canada, “Daily Planet” science programme segment highlighting the capabilities of the NML when an unknown pathogen appears in Canada, Monday, January 24th 2011: coverychannel.ca/daily-planet/march-2010/daily-planet---march-11-2010/#clip406907 (starts at about the 7:45 minute mark).
Eric Bow
October 20, 2010 Palliative Care Education Series, Winnipeg, MB
Presentation: "Approach to the management of infections in patients with terminal cancer. Be mindful of the goals of treatment."
October 21, 2010 Department of Pediatrics Grand Rounds, University of Manitoba
Presentation: “Fungal Therapy in Immunocompromised Hosts”
November 9, 2010 Saskatoon Haematology/Oncology and ID Physician Group, Saskatoon, SK
“Managing Fungal Infections in the HSCT Patient”
December 4, 2010 ASH Symposium with Japanese Haematologists, Orlando, Florida
“Pre-emption vs Prevention vs Empiricism vs Directed Therapy”
January 31, 2011 Canadian Association of Nurses in Oncology (CANO) Manitoba Chapter Winnipeg MB
"Approach to the management of infections in patients with terminal cancer. Be mindful of the goals of treatment."
May 28, 2011 2nd PRIME Summit: Pfizer Regional Anti-Infectives Meeting for Excellence
Kunming, China
“IFI in leukemic and BMT Patients: Recent guidelines and clinical relevance”
June 1, 2011 Special BMT Rounds: Princess Margaret Hospital, Toronto, ON
“Management of Fungal Infections in the HSCT Patient: Complex Cases”
June 2, 2011 Hematology Lecture Series, Vancouver General Hospital, Vancouver, BC
“Of Conidia & Nodularities … High-Risk Patient-Centred Stuff We Should Think About”
June 8, 2011 Symposium: Mucosal barrier injury, innate immunity and infection
Radboud University, Nijmegen, The Netherlands
“Consequences and infectious complications”
June 25, 2011 Infectious Disease Conference 2011, Hong Kong
Co-organized by the Hospital Authority Infectious Disease Centre, Hong Kong,
Department of Medicine & Geriatrics, Princess Margaret Hospital and
The Hong Kong Society for Infectious Diseases
Presentations: “Management of Neutropenic Fever” and
“Fungal infection in immunocompromised patients”
Jared Bullard
What We Should Know About Pneumococcal Disease in Kids. Invited speaker to the Canadian Respiratory Conference in Niagra Falls, Ontario (May 2011).
A Case of HIV MTCT in Manitoba in 2010 and Review of Epidemiological and Clinical Characteristics of Maternal and Pediatric HIV in Manitoba, Canada from 1989 to 2010.
Invited speaker to the Manitoba HIV Program’s CME Guest Lecture Series, Winnipeg, Manitoba (April 2011)
HIV Testing: An Update for 2010.
Invited presenter to the Department of Pediatrics Small Group Discussion (September 2010).
David Butler-Jones
2010-07-17: AIDS 2010 Conference - Indigenous Peoples Satellite, Vienna Austria
2010-08-22: IPAC Conference - session on Pandemic Planning, Toronto, ON
2010-08-25: Canada 55+ Games, Brockville, ON
2010-08-30: Remarks to Staff - Winnipeg Town Hall, Winnipeg MB
2010-08-31: Speech to Kiwanis Golden K, Barrie, ON
2010-09-01: Federation of Canadian Municipalities, Iqaluit, NU
2010-09-01: Remarks to National Collaborating Centre for Aboriginal Health Advisory Committee, Iqaluit, NU
2010-09-14: Remarks to Infectious Disease Prevention and Control Branch Staff Retreat, Ottawa, ON
2010-09-15: Agricultural Biotechnology Conference International Conference, Saskatoon, SK
2010-09-26: International Society of Hypertension - presentation on Cardiovascular Health, Vancouver, BC
2010-09-26: International Society of Hypertension Conference - opening remarks, Vancouver, BC
2010-09-29: Appearance Before the Senate Social Affairs Committee on Pandemic Preparedness, Ottawa, ON
2010-09-29: Remarks for a visit by the Canada School of Public Service - Leadership Across Borders Program, Ottawa, ON
2010-10-06: Appearance Before the Senate Social Affairs Committee on Pandemic Preparedness re: vaccines, Ottawa, ON
2010-10-14: Remarks for an Assistant Deputy Minister Forum, Gatineau, QC
2010-10-14: Keynote Address at the Canadian Public Health Association Biennial Meeting - Fredericton, NB
2010-10-21: Presentation at the Gairdner International Vaccine Symposium, Saskatoon, SK
2010-10-26: Presentation at ‘Championing Public Health Nutrition’: A Dialogue with the Canadian Centre for Science in the Public Interest, Ottawa, ON
2010-10-27: Keynote Address to the Aboriginal Nurses Association of Canada Conference, Toronto, ON
2010-11-04: Opening remarks at a Workshop on Hepatitis C, Ottawa, ON
2010-11-04: Appearance before the Standing Committee on progress on Weatherill recommendations, HESA, Ottawa, ON
2010-11-21: Presentation on the CPHO’s 2010 report, Journées Annuelles de la Sante Publique, Québec City, QC
2010-11-25: Appearance before the Standing Committee on Supplementary Estimates 'B', HESA, Ottawa, ON
2010-11-29: Remarks for the 2nd Task Force Meeting on Prevention, Ottawa, ON
2010-12-01: Remarks at the Deputy Minister’s Breakfast on the CPHO’s 2010 Report, Ottawa, ON
2010-12-01: Remarks to National Microbiology Staff on World AIDS Day (teleconference)
2010-12-04: Speech to the Canadian Association on Gerontology's 39th Annual Scientific and Educational Meeting, Montreal, QC
2010-12-06: Remarks at the Canadian Immunization Conference, Quebec City, QC
2010-12-07: Panel Discussion at the Global Health Symposium, Ottawa, ON
2010-12-10: Remarks for an Institute of Population and Public Health Intervention Research Symposium, Toronto, ON
2010-12-10: Remarks for a PHAC Executive Committee Retreat, Ottawa, ON
2011-01-05: Welcoming Remarks for the Canadian Public Health Association Centenary Exhibit, Ottawa, ON
2011-01-06: Guest Lecture at the University of Manitoba’s H1N1 Seminar, Winnipeg, MB
2011-01-10: Keynote Remarks at the Insight Conference on Chronic and Complex Health Care, Halifax, NS
2011-01-24: Remarks (x3) for a PHAC Town Hall, Ottawa, ON
2011-02-09: Welcoming Remarks for an International Influenza Seroprevalence Meeting, Ottawa, ON
2011-02-14: Presentation - Breaking Down Barriers, Creating Connections - One Health Australia, Melbourne
2011-02-16: Presentation - Science, Policy and Political Action - One Health Australia, Melbourne
2011-02-21: Presentation to the Public Health Association of Australia, Canberra
2011-03-10: Appearance Before the Standing Committee on Supplementary Estimates "C" – HESA, Ottawa, ON
2011-03-11: Guest Lecture at the University of Manitoba’s 17th Annual Research Forum - Aging and Seniors, Winnipeg, MB
2011-03-22: Remarks for the Childhood Obesity Engagement Strategy - Preventing Childhood Obesity - Moving Policy Recommendations to Action, Ottawa, ON
2011-03-24: Welcoming Remarks to the FASDONE Provincial Conference, Toronto, ON
2011-03-25: Remarks for a BC Town Hall for PHAC staff, Vancouver, BC
2011-03-25: Remarks for a Multiple Sclerosis Announcement with the Minister of Health, Ottawa, ON
2011-03-26: Metropolis Conference - Plenary presentation on Immigration, Diversity and Public Health, Vancouver, BC
2011-03-28: Welcoming Remarks at the National Aboriginal Council on HIV/AIDS, Ottawa, ON
2011-03-29: Remarks at the PHAC Science and Research Forum, Gatineau, QC
2011-04-06: Welcoming remarks at the Ontario Public Health Convention, Toronto, ON
2011-05-12: Remarks at the World Health Assembly 2011, Geneva, Switzerland
2011-05-26: Presentation to the Heads of Federal Agencies Learning Day, Ottawa, ON
2011-06-02: Presentation to Canadian Hospital Acquired Infections Association Canada, Toronto, ON
2011-06-06: Welcoming remarks at the Field Services Training Institute, Vancouver, BC
Jingxin Cao
Department of Anatomy and Physiology, Kansas State University, Manhattan, Kansas, USA, April 25 2011,
Application of vaccinia E3L deletion mutant based system for study of viral dsRNA `binding proteins: Inhibition of cytokine induction and interferon antiviral state .
Department of Applied Chemistry, National Chia-Yi University, Taiwan, May 30 2011, Dual activities of vaccinia E3 protein: inhibition of cytokine expression and IFN-indcued antiviral activities .
Institute of Chemistry, Academia Sinica, Taipei, Taiwan, May 31 2011, Identification of vaccinia RNA species as PAMPs and mutagenesis studies of vaccinia E3 protein for its role in interfering with vaccinia PAMP-induced antiviral activities .
Kevin Coomba
2010. Proteomics of influenza virus-infected human cells. Pandemic Preparedness Strategic Research Initiative; Outcomes, Impacts and Lessons Learned, Montreal, November 12.
2010. Measuring global host protein responses to virus infections. Keynote Address. International Conference of Communicable Diseases Surveillance and Prospects of Laboratory Testing, Bitumi, Republic of Georgia, November 22.
Michael Drebot
Invited Speaker and Session Expert, Drebot MA: American Association of Tissue Banks Consultation Workshop. “West Nile virus: Scientific considerations for tissue donors”. April 23, 2010. Washington DC.
Invited Speaker, Drebot MA. Emerging Infectious Disease. Biophotonics Workshop. Quebec City, Quebec. September 22-23, 2010.
Invited speaker and Session Expert / Consultant, Drebot MA: Grand Challenges of Canada - Diagnostic Development Initiatives for 3rd World Countries. Toronto, Ontario, September 29, 2010.
Invited Speaker, Drebot M. Diagnostic considerations for emerging zoonotic disease. Zoonotic Diseases Symposium, Annual Review Meeting of the University of Nairobi STD/AIDS Collaborative Group. Nairobi, Kenya. January 26-29, 2011.
Invited Speaker, Drebot MA. An Overview of California Serogroup Virus Diagnostics and Surveillance in Canada in 2010. National Meeting on West Nile virus and Other Non-Enteric Zoonotic Diseases, Jan 21-22, Ottawa, Ontario, 2011.
John Embil
A View from the Trenches: Case Histories in Infectious Diseases. Primary Care Update, Winnipeg Convention Centre, October 1, 2010.
Medical Grand Rounds: Infection Control: Never a Dull Moment! University of Manitoba, October 19, 2010.
Ophthalmology Grand Rounds: Infectious Diseases Potpourri. Misericordia Health Centre, Winnipeg, Manitoba, November 3, 2010.
Report from the Vancomycin Resistant Enterococcus Working Group. Canadian Nosocomial Infections Surveillance Programs/Canadian Hospital Epidemiology Committee Annual General Meeting, Ottawa, Ontario, November 15, 2010.
The Good, The Bad, The Ugly: The Diabetic Foot and the Future of Pedorthics. Key Note Presentation at 2010 North American Pedorthic Congress, Orlando, Florida, November 20, 2010
Wound Care: Science or Witchcraft. 2010 North American Pedorthic Congress, Orlando, Florida, November 20, 2010.
Infection Control and C. difficile. Clostridium difficile Associated Disease – CDAD Symposium. University of Manitoba, December 7, 2010.
Hand Hygiene – Our Dirty Little Secret. Winnipeg Regional Health Authority Critical Care Quality Symposium 2011. March 3, 2011.
A Bone to PICC: Intravenous versus Oral Therapy for the Management of Diabetic Foot Osteomyelitis DF Con 2011: Diabetic Foot Global Conference, Los Angeles, California, March 25, 2011.
Healing Resource Wounds through the Use of Evidence: The Silver Lining in a Vacuum of Evidence. 2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Symposium, Vancouver, British Columbia, April 3-5, 2011.
Panel Discussion: Health Technology Assessments for Health System Sustainability: Opportunities and Challenges. 2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Symposium, Vancouver, British Columbia, April 3-5, 2011.
Science versus Witchcraft in the Management of the Diabetic Foot. Winnipeg Vascular and Endovascular Symposium, Winnipeg, Manitoba, April 7, 2011.
What to do with What Lurks Beneath the Dressing: Managing the Diabetic Foot. First Nations and Inuit Branch – Health Canada. Winnipeg, Manitoba, April 14, 2011.
Antibiotics and Clinical Practice. First Nations and Inuit Branch – Health Canada. April 14, 2011, Winnipeg, Manitoba.
Chronic Disease Management Symposium: The VIPS of Diabetic Foot Care. Winnipeg, Manitoba, May 7, 2011.